B-Secur

B-Secur is dedicated to advancing health technology through innovative software development. With a commitment to reducing preventable deaths from cardiovascular disease (CVD), B-Secur utilizes clinically validated biosensing algorithms that enable early diagnosis and proactive health management. The company’s expertise in noise artifact detection and reduction, cultivated through decades of academic R&D in ECG analysis and front-end design, delivers FDA-cleared clinical-grade ECG solutions for next-generation wearable health devices and platforms.

B-Secur's HeartKey® is a suite of powerful ECG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights. Their solutions are platform agnostic, offering high accuracy on dry electrodes in real-time and utilizing proprietary AI machine-learning and filter techniques. B-Secur partners with world-leading technology companies to enable innovation, speed to market, and operational efficiencies for next-generation medical and consumer devices and platforms. The primary address of B-Secur is 11th Floor, City Quays 3, 92 Donegall Quay, Belfast, BT1 3FE, GB; they also have a location in San Francisco, US.

B-Secur continues to drive advancements in EKG health and wellness through cutting-edge software development and strategic partnerships. The company's focus on EKG analysis and biosensing technology positions it as a leader in the MedTech industry. B-Secur is at the forefront of developing solutions that improve heart health and overall wellness. We invite the manager of B-Secur to create a customized and exclusive company showcase and product listing on our platform.